Polydex Pharmaceuticals Ltd POLXF:OTCPK

RT Quote | Exchange | USD
Last | 02/24/21 EST
1.04UNCH (UNCH)
52 week range
0.80 - 1.20

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.04
  • 52 Week High1.20
  • 52 Week High Date03/02/20
  • 52 Week Low0.80
  • 52 Week Low Date07/10/20
  • Market Cap3.56M
  • Shares Out3.42M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.52
  • 1 Year % Change-15.45

RATIOS/PROFITABILITY

  • EPS (TTM)0.02
  • P/E (TTM)52.82
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)446,490.00
  • ROE (MRQ)0.95%
  • Revenue (MRQ)4.89M
  • Gross Margin (MRQ)16.57%
  • Net Margin (MRQ)1.16%
  • Debt To Equity (MRQ)7.98%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Polydex Pharmaceuticals Ltd News

There is no recent news for this security.

Latest POLXF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Polydex Pharmaceuticals Limited is engaged in the development, manufacture and marketing of biotechnology-based products for the human pharmaceutical market. Its principal business activities, carried on through subsidiaries, include the manufacture and sale of veterinary pharmaceutical products and specialty chemicals. The Company also manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry. The Company focuses on the manufacture and sale of...
George Usher
Chairman
Sharon Wardlaw
Chief Operating Officer
John Luce
Chief Financial Officer
Address
421 Comstock Rd
Scarborough, ON
M1L 2H5
Canada